<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="5742">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03032198</url>
  </required_header>
  <id_info>
    <org_study_id>Thyroid-01</org_study_id>
    <nct_id>NCT03032198</nct_id>
  </id_info>
  <brief_title>&quot;Clinical Evaluation of Opto-Acoustic Tomography for Detection and Diagnostic Differentiation of Thyroid Nodules&quot;</brief_title>
  <official_title>&quot;Clinical Evaluation of Opto-Acoustic Tomography for Detection and Diagnostic Differentiation of Thyroid Nodules&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seno Medical Instruments Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seno Medical Instruments Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thyroid Feasibility Study
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2017</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Initial assessment of Imagio's ability to distinguish between benign and malignant thyroid nodules.</measure>
    <time_frame>12-24 months</time_frame>
    <description>The primary objective of this feasibility study is to provide an initial assessment of Imagio OA's ability to distinguish between benign and malignant thyroid nodules, and when appropriate, between benign and metastatic cervical lymph nodes in subjects.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Feasibility Study for Thyroid Indication</condition>
  <arm_group>
    <arm_group_label>Imagio Scan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be scanned and imaged with Imagio.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Imagio Imaging System</intervention_name>
    <description>The Imagio system is a diagnostic functional and morphologic imaging system intended for the opto-acoustic (OA) evaluation of thyroid in men and/or women who have findings of thyroid nodules.</description>
    <arm_group_label>Imagio Scan</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have an undiagnosed suspicious solid or mostly solid thyroid nodule

          -  Have received recommendation for and are scheduled for biopsy

        Exclusion Criteria:

          -  Previous or on-going radioactive iodine treatment.

          -  Have greater than 2 nodules (1 in each lobe) recommended for biopsy at baseline

          -  Previous biopsy of target nodule
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shaan Schaeffer</last_name>
    <phone>210-615-6501</phone>
    <email>sschaeffer@senomedical.com</email>
  </overall_contact>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 31, 2017</lastchanged_date>
  <firstreceived_date>January 20, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Thyroid Nodule</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
